Delivery Order SPE2DB24D1205-SPE2DB25FCXJE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,785.44 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract is classified as a delivery order and will be performed at the contractor's location in Conshohocken, Pennsylvania. Sprycel is a targeted cancer therapy medication, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Sprycel 100 mg tablets (30-count units) valued at $9,298.59. This firm fixed-price, non-set-aside delivery order is scheduled for completion by June 10, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Sprycel is a critical oncology medication used in cancer treatment protocols, reflecting the federal government's ongoing...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,156.18 to AmerisourceBergen Drug Corp for Sprycel 50 mg tablets (quantity: 60 units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $11,013.24 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count packaging) on June 9, 2025, with a completion date of June 10, 2025. This firm fixed-price, non-set-aside delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,667.58 to AmerisourceBergen Drug Corp for the supply of Sprycel 50 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order was issued on May 19, 2025, with an ultimate completion date of May 20, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Sprycel is a targeted cancer therapy medication, and this delivery order represents a...
- The Defense Logistics Agency awarded a $5,665.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award carries no set-aside designation and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills this order as a...
- The Defense Logistics Agency awarded a delivery order valued at $13,143.67 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing under a delivery order contract type and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,964.90 to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count units) on July 17, 2025, with completion scheduled for July 18, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,578.09 to AmerisourceBergen Drug Corp for Sprycel 50 mg tablets (60-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sprycel 140 mg tablets (30-count units) under a firm fixed-price contract. The delivery order, valued at $5,570.37 with a completion date of July 29, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXJEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,223.00 to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count) on June 3, 2025, with an ultimate completion date of June 4, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Sprycel is a targeted cancer therapy medication, and this delivery supports the federal military healthcare supply chain. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total potential value of $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp has demonstrated substantial capability in fulfilling federal medical procurement requirements through multiple competitively awarded contracts with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.2k | 6/3/25 |